Antibiotic allergy in cystic fibrosis

Thorax

Volumn 60, Issue 6, 2005, Pages 517-520

  Parmar, J S ^b   Nasser, S ^a  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b PAPWORTH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALKYL GROUP; ALLERGEN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIHISTAMINIC AGENT; AZITHROMYCIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM DERIVATIVE; CARBENICILLIN; CEFTAZIDIME; CIPROFLOXACIN; CLARITHROMYCIN; DRUG METABOLITE; ERYTHROMYCIN; IMIPENEM; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; MACROLIDE; MEZLOCILLIN; MONOBACTAM; PENICILLIN DERIVATIVE; PIPERACILLIN; PLACEBO; STEROID; SULFONAMIDE; TOBRAMYCIN; TRYPTASE;

ABDOMINAL DISCOMFORT; ANAPHYLAXIS; ANGIONEUROTIC EDEMA; ANTIBIOTIC THERAPY; ARTHRALGIA; BACTERIAL INFECTION; BLOOD TOXICITY; BRONCHOSPASM; CLINICAL FEATURE; CLINICAL TRIAL; CROSS REACTION; CYSTIC FIBROSIS; DESENSITIZATION; DIARRHEA; DRUG CHOICE; DRUG ERUPTION; DRUG HYPERSENSITIVITY; DRUG MEGADOSE; DRUG SAFETY; DRUG SELF ADMINISTRATION; DRUG STRUCTURE; DRUG TOLERABILITY; DRUG UTILIZATION; EOSINOPHILIA; FEVER; GASTROINTESTINAL SYMPTOM; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOGENICITY; IMMUNOLOGICAL TOLERANCE; INCIDENCE; LETHARGY; LIVER DYSFUNCTION; MEDICAL RECORD; MYALGIA; NAUSEA; PATIENT EDUCATION; PREDICTION; PRICK TEST; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RASH; REVIEW; RISK ASSESSMENT; RISK FACTOR; SKIN MANIFESTATION; STENOTROPHOMONAS MALTOPHILIA; STEVENS JOHNSON SYNDROME; SURVIVAL RATE; TOXIC EPIDERMAL NECROLYSIS; URTICARIA; VOMITING;

ANTI-BACTERIAL AGENTS; CYSTIC FIBROSIS; DRUG HYPERSENSITIVITY; DRUG INTERACTIONS; HUMANS; RISK FACTORS;

EID: 20444477989     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thx.2004.027953     Document Type: Review

References (37)

1. Griesenbach U, Geddes D, Alton E. The pathogenic consequences of a single mutated CFTR gene. Thorax 1999;54:S19-23.
2. Bals R, Weiner D, Wilson J. The innate immune response in cystic fibrosis lung disease. J Clin Invest 1999;103:303-7.
3. Wills R, Henry RL, J Francis. Antibiotic hypersensitivity reactions in cystic fibrosis. J Paediatr Child Health 1998;43:325-9.
4. Mahadeva R, Webb K, Westerbeek R, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. BMJ 1998;316:1771-5.
5. Littlewood J, Bevan A, Connett G, et al. Antibiotic treatment in cystic fibrosis, Report of the UK CF Trust Antibiotic Group, 2002.
6. Koch C, Pedersen S, Jensen E, et al. Retrospective clinical study of hypersensitivity reactions to aztreonam and six other beta-lactam antibiotics in cystic fibrosis patients receiving multiple treatment courses. Rev Infect Dis 1991;13:S608-11.
7. Pleasants R, Samuelson W. Allergic reactions to parenteral beta-lactam antibiotics in patients with cystic fibrosis. Chest 1994;106:1124-8.
8. McDonnell T, Parker F. Cystic fibrosis and penicillin hypersensitivity. Lancet 1984;i:1301-2.
9. Ramesh S. Antibiotic hypersensivity in patients with CF. Clin Rev Allergy Immunol 2002;23:123-39.
10. Girard J. Common antigenic determinants of penicillin G, ampicillin and the cephalosporins demonstrated in men. Int Arch Allergy Appl Immunol 1968;33:428-38.
11. Blanca M, Fernandez J, Miranda A, et al. Cross-reactivity between penicillins and cephalosporins: clinical and immunologic studies. J Allergy Clin Immunol 1989;83:381-5.
12. Audicana M, Bernaola G, Urrutia I, et al. Allergic reactions to betalactams: studies in a group of patients allergic to penicillin end evaluation of cross-reactivity with cephalosporin. Allergy 1994;49:108-13.
13. Shepherd GM, Burton DA. Administration of cephalosporin antibiotics to patients with a history of penicillin allergies. J Allergy Clin Immunol 1993;91:262.
14. Novalbos A, Sastre J, Cuesta J, et al. Lack of allergic cross-reactivity to cephalosporins among patients allergic to penicillins. Clin Exp Allergy 2001;31:438-43.
15. Sheppard D, Welsh M. Structure and function of the CFTR chloride channel. Physiol Rev 1999;79:S23-45.
16. Saxon A, Beall G, Rohr A, et al. Immediate hypersensitivity reactions to beta-lactam antibiotics. Ann Intern Med 1987;107:204-8.
17. Solley GO, Gleich GJ, Van Dellen RG. Penicillin allergy: clinical experience with a battery of skin-test reagents. J Allergy Clin Immunol 1982;69:238-44.
18. Assem ES, Vickers MR. Tests for penicillin allergy in man. II. The immunological cross-reaction between penicillins and cephalosporins. Immunology 1974;27:255-69.
19. Jensen T, Pedersen S, Hoiby N. Aztreonam for cystic fibrosis patients who are hypersensitive to other beta-lactams. Rev Infect Dis 1991;13:S594-7.
20. Moss R, McClelland E, Williams R, et al. Evaluation of the immunologic crossreactivity of aztreonam in patients who are allergic to penicillin and cephalopsporins. Rev Infect Dis 1991;13(Suppl):S598-607.
21. Schretlen-Doherty J. Tobramycin-induced hypersensitivity reaction. Ann Pharmacother 1995;29:704-6.
22. Spigarelli M, Nasr S. Hypersensitivity to inhaled TOBI following reaction to gentamyicin. Pediatr Pulmonol 2002;33:311-4.
23. Equi A, Balfour-Lynn I, Bush A, et al. Long term azithromycin in children with cystic fibrosis: a radomised, placebo-controlled crossover trial. Lancet 2002;360:978-84.
24. Saiman L, Marshall BC, Mayer-Hamblett N, et al. Azithromycin in patients with cystic fibrosis infected with Pseudomonas aeruginosa. JAMA 2003;290:1749-56.
25. Wolter J, Seeney S, Bell S, et al. Effect of long term treatment with azithromycin on disease parameters in cystic fibrosis: a randomised trial. Thorax 2002;57:212-6.
26. Warner J, Taylor B, Norman A, et al. Atopy and hypersensitivity reactions in children. Arch Dis Child 1976;51:507-11.
27. Pichler W. Delayed hypersensitivity reactions. Ann Intern Med 2003;139:683-93.
28. Sastre J, Quijano L, Novalbos A, et al. Clinical cross-reactivity between amoxicillin and cephadroxil in patients allergic to amoxicillin and with good tolerance of penicillin. Allergy 1996;51:383-6.
29. Romano A, Mayorga C, Torres MJ, et al. Immediate allergic reactions to cephalosporins: cross-reactivity and selective responses. J Allergy Clin Immunol 2000;106:1177-83.
30. Baldo B, Pham N. Immunoglobulin E binding determinants of beta-lactam drugs. Curr Opin Allergy Clin Immunol 2002;2:297-300.
31. Torres M, Mayorga C, Pamies R, et al. Immunological response to different determinants of benzylpenicillin, amoxicillin and ampicillin. Comparison between urticaria and anaphylactic shock. Allergy 1999;54:936-43.
32. Peirce T, Ingram P. Ceftazidime in the treatment of lower respiratory tract infection. J Antimicrob Chemother 1983;12:21-5.
33. Ghosal S, Taylor C. Intravenous desensitization to ceftazidime in cystic fibrosis patients. J Antimicrob Chemother 1997;39:556-7.
34. Earl H, Sullivan TJ. Acute desensitisation of a patient with CF to both beta-lactam and aminoglycoside antibiotics. J Allergy Clin Immunol 1987;79:477-83.
35. Lantner R. Ciprofloxacin desensitisation in a CF patient. J Allergy Clin Immunol 1995;96:1001-2.
36. Wilson D, Owens RJ, Zuckerman J. Successful meropenem desensitization in a patient with cystic fibrosis. Ann Pharmacother 2003;37:1424-8.
37. Burrows J, Toon M, Bell S. Antibiotic desensitisation in adults with cystic fibrosis. Respirology 2003;8:359-64.